SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Huang, L.
Right arrow Articles by Fang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, L.
Right arrow Articles by Fang, X.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Carvedilol Mitigates Adverse Effects of Epinephrine During Cardiopulmonary Resuscitation

Lei Huang, MD

The Institute of Critical Care Medicine, Palm Springs, CA

Max Harry Weil, MD, PhD

The Institute of Critical Care Medicine, Palm Springs, CA, Keck School of Medicine, University of Southern California, Los Angeles, CA, Feinberg School of Medicine, Northwestern University, Chicago, IL, weilm{at}911research.org

Shijie Sun, MD

The Institute of Critical Care Medicine, Palm Springs, CA, Keck School of Medicine, University of Southern California, Los Angeles, CA

Wanchun Tang, MD

The Institute of Critical Care Medicine, Palm Springs, CA, Keck School of Medicine, University of Southern California, Los Angeles, CA

Xiangshao Fang, MD

The Institute of Critical Care Medicine, Palm Springs, CA

Introduction: Earlier studies have implicated the adverse effects of ß- and {alpha}1-adrenergic receptors during cardiopulmonary resuscitation (CPR). Because carvedilol is both a nonselective ß- and {alpha}1-selective adrenergic receptor-blocking agent, we hypothesized that pre-treatment with carvedilol would convert the actions of epinephrine to that of a selective a2-agonist.

Methods: Ventricular fibrillation (VF) was induced in Sprague-Dawley rats weighing approximately 500 g. Animals were randomized to 4 groups of 5 animals each: (1) placebo pretreatment and epinephrine treatment, (2) carvedilol pretreatment and placebo treatment, (3) carvedilol pretreatment and epinephrine treatment, and (4) placebo pretreatment and placebo treatment. Carvedilol (50 µg/kg) was injected as a bolus into the right atrium 15 minutes before VF was induced. VF was untreated for 8 minutes, after which CPR (chest compression and mechanical ventilation) was begun. Epinephrine (30 µg/kg) was injected into the right atrium 2 minutes after the start of CPR. Electrical defibrillation was attempted after 14 minutes of VF.

Results: All but 2 animals were successfully resuscitated. Approximately equivalent increases in coronary perfusion pressure from 23 ± 1 mm Hg to 30 ± 3 mm Hg were observed after the injection of epinephrine independently of carvedilol pretreatment. Carvedilol pretreatment followed by epinephrine treatment reduced early postresuscitation ventricular ectopy (116 ± 147 vs 834 ± 380, P < .01) and minimized increases in arterial blood lactate at 5 minutes after resuscitation (10.9 ± 2.1 mmol/L vs 17.4 ± 3.5 mmol/L, P < .01). The postresuscitation cardiac index measured 4 hours later was increased (307 ± 43 mL • min-1• kg-1 vs 210 ±6 mL • min-1• kg-1, P <.05). Left ventricular diastolic pressures were decreased (6 ± 1 vs 14 ± 1 mm Hg, P < .05). Animals pretreated with carvedilol survived longer (71 ± 1 vs 45 ± 22 hours, P < .05) and with less postresuscitation neurologic deficit.

Conclusion: After ß- and {alpha}1-adrenergic blockade with carvedilol before inducing cardiac arrest, epinephrine administered during CPR yielded better postresuscitation myocardial and neurologic functions and significantly increased postresuscitation survival.

Key Words: adrenergic receptors • cardiac arrest • CPR • coronary perfusion pressure • ventricular fibrillation

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 10, No. 2, 113-120 (2005)
DOI: 10.1177/107424840501000205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. Harvey, G. Cave, and A. Kazemi
Intralipid Infusion Diminishes Return of Spontaneous Circulation After Hypoxic Cardiac Arrest in Rabbits
Anesth. Analg., April 1, 2009; 108(4): 1163 - 1168.
[Abstract] [Full Text] [PDF]



Advertisement